Health Care Sector Update for 12/13/2018: AGTC, AMPE, VVUS, JNJ, PFE, ABT, MRK, AMGN
Top Health Care Stocks:
Pre-bell Thursday saw mostly flat health care stocks.
Early movers include:
(-) Applied Genetic Technologies ( AGTC ), which was down more than 36% after it reported topline interim six-month data from its phase 1/2 clinical trial of rAAV2tYF-CB-hRS1, an investigational AAV-based gene therapy delivered via intravitreal injection for X-linked retinoschisis, or XLRS, due to mutations in the RS1 gene.
(-) Ampio Pharmaceuticals ( AMPE ) was falling more than 25% after saying the US Food and Drug Administration’s Office of Tissue and Advanced Therapies has called on Ampio to complete an additional trial of KL4 osteoarthritis patients treated with Ampion.
(+) VIVUS ( VVUS ) was more than 8% higher after the company said in a regulatory filing beginning Jan. 1, Sanofi Chimie will manufacture and supply the active pharmaceutical ingredient (API) for VIVUS’ drug avanafil on an exclusive basis in all countries where VIVUS has the right to sell avanafil. The agreement will expire Dec. 31, 2023 unless either party makes a timely election to terminate the agreement and the pact will auto-renew for successive one-year terms unless either party makes a timely election not to renew.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.
Zeen is a next generation WordPress theme. It’s powerful, beautifully designed and comes with everything you need to engage your visitors and increase conversions.
Go to Appearance > Customize > Subscribe Pop-up to set this up.
Wealth Empire Newsletter
Register now for free updates and alerts
Note: I have the ability to revoke this permission at any time and ask for the removal of my personal data collected by contacting us or simply clicking Unsubscribe.